Amgen (AMGN +0.3%) bucks a weak tape on positive comments out of Baird this morning ahead of its Q2 report. The firm says it's anticipating the company to beat expectations, citing its strong operational upside and insulation from weak macro conditions. Stock momentum should also be aided by additional stockholder incentives such as dividend raises and buybacks, and it raises its price target to $79 from $75.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs